Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07316543 · ClinicalTrials.gov registry record · NA
Cognitive Rehabilitation for Veterans With PNES
A NA study of Psychogenic Nonepileptic Seizures (PNES), sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- NA
- Development phase
- 47
- Enrollment target
- 1
- Study location
NCT07316543: Recruiting NA study of Psychogenic Nonepileptic Seizures (PNES), sponsored by VA Office of Research and Development.
NCT07316543 is a NA study of Psychogenic Nonepileptic Seizures (PNES) that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 47 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07316543, a NA study of Psychogenic Nonepileptic Seizures (PNES), is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
- 1
- Study location
Study Summary
Psychogenic nonepileptic seizures (PNES) reflect a subtype of functional neurological disorder (FND) that is common and extremely disabling in Veterans. Cognitive problems are highly prevalent in PNES, they reduce quality of life, and they severely limit daily functioning. Currently, there are no available treatments that target cognition to improve daily function in PNES or other FNDs, leaving a major gap in the literature. Cognitive re-habilitation improves daily functioning in Veterans with related neuropsychiatric disorders and has a high chance of success in Veterans with PNES. The proposed study will solicit direct input from Veterans with PNES via qualitative interviews to inform the design of a cognitive treatment workbook. The workbook will then be iteratively refined based on participatory feedback from Veterans with PNES and their treatment providers. The full cognitive intervention protocol will be pilot tested to inform a fully powered RCT. Results will support a line of research that aims to improve cognition and function in Veterans with PNES and related FNDs.
Primary Outcome
Everyday functioning as measured by the World Health Organization Disability Assessment Schedule 2.0, range = 0-100, higher scores = greater disability.
Conditions Studied
Interventions
- BEHAVIORAL Cognitive Rehabilitation And Functional Treatment (CRAFT)
Study Locations (1)
Rhode Island
- Providence VA Medical Center, Providence, RI - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2026-03-02 |
| Est. Completion | 2031-07-01 |
| Phase | NA |
What NCT07316543 shows while recruiting
NCT07316543 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 47 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Psychogenic Nonepileptic Seizures (PNES) appearing as the primary indexed condition, and to 1 intervention - of which Cognitive Rehabilitation And Functional Treatment (CRAFT) is the first listed.
NCT07316543 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT07316543 about?
NCT07316543 is a clinical study titled "Cognitive Rehabilitation for Veterans With PNES". Psychogenic nonepileptic seizures (PNES) reflect a subtype of functional neurological disorder (FND) that is common and extremely disabling in Veterans. Cognitive problems are highly prevalent in PNES, they reduce quality of life, and they severely limit daily functioning. Currently, there are no av...
What is the current status of trial NCT07316543?
This trial is currently recruiting. It is a NA study. The enrollment target is 47 participants. The study started on 2026-03-02. Estimated completion is 2031-07-01.
What conditions does trial NCT07316543 study?
This clinical trial studies the following conditions: Psychogenic Nonepileptic Seizures (PNES).
What interventions are being tested in trial NCT07316543?
The interventions under investigation include: Cognitive Rehabilitation And Functional Treatment (CRAFT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT07316543?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07316543 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07316543's enrollment target sits among peer trials
47 1400th of 2000 higher than 599 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03313011 · 47 participants
The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
- NCT03467516 · 47 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma
- NCT03886662 · 47 participants · Phase 1
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
- NCT04013802 · 47 participants · Phase 1
TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI